Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer

NCT04489940 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued by the sponsor due to probability of success which was too low to justify the continuation of recruitment.

Conditions

Interventions

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators